Aclaris Therapeutics (ACRS) Inventory (2018 - 2019)
Aclaris Therapeutics (ACRS) posted quarterly Inventory of $189000.0 for Q3 2019, down 81.9% year-over-year from $1.0 million in Q3 2018, and up 2.16% quarter-over-quarter from $185000.0 in Q2 2019.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Inventory (2018 - 2019) Analysis & Trends
Aclaris Therapeutics' Inventory history runs 2 years deep, the most recent figure standing at $189000.0 for Q3 2019.
- In Q3 2019, Inventory fell 81.9% year-over-year to $189000.0; the TTM figure through Sep 2019 stood at $189000.0 (down 81.9% YoY), while the FY2018 annual figure was $791000.0, changed N/A from the prior year.
- Inventory for Q3 2019 stood at $189000.0, up from $185000.0 in the prior quarter.
- The five-year high for Inventory was $1.0 million in Q3 2018, with the low at $185000.0 in Q2 2019.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.27 Bn | 131.42 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.55 Bn | 77.56 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.45 Bn | 58.27 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 57.73 Bn | 52.59 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.08 Bn | 44.08 Bn | - | - |
| 6 | BeOne Medicines | 39.95 Bn | 34.85 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.14 Bn | 31.84 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Aclaris Therapeutics | 877.83 Mn | 877.83 Mn | 1.41 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2019 | 189,000.00 |
| Jun 30, 2019 | 185,000.00 |
| Mar 31, 2019 | 856,000.00 |
| Dec 31, 2018 | 791,000.00 |
| Sep 30, 2018 | 1.04 Mn |
| Jun 30, 2018 | 1.03 Mn |